Quick Answer
XBiotech Inc. reported Stockholders Equity of $140.35 million for the year ending 2025.
- XBiotech Inc. showed a decrease of -23.0% in Stockholders Equity from 2024 to 2025.
- This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $123.98 million | Q3 2015: $114.08 million | Q1 2016: $94.68 million | Q2 2016: $82.80 million | Q3 2016: $71.63 million | Q1 2017: $82.27 million | Q2 2017: $73.16 million | Q3 2017: $67.15 million | Q1 2018: $56.41 million | Q2 2018: $51.52 million | Q3 2018: $46.94 million | Q1 2019: $36.98 million | Q2 2019: $69.41 million | Q3 2019: $64.62 million | Q1 2020: $347.08 million | Q2 2020: $343.57 million | Q3 2020: $346.14 million | Q1 2021: $352.10 million | Q2 2021: $348.56 million | Q3 2021: $274.16 million | Q1 2022: $265.56 million | Q2 2022: $255.80 million | Q3 2022: $244.81 million | Q1 2023: $236.91 million | Q2 2023: $229.06 million | Q3 2023: $222.66 million | Q1 2024: $209.28 million | Q2 2024: $196.70 million | Q3 2024: $192.12 million | Q1 2025: $174.71 million | Q2 2025: $173.06 million | Q3 2025: $167.08 million.
- Over the full 14 years of available data (2012 to 2025), XBiotech Inc.'s Stockholders Equity has grown by 1,803.8%.
- Historical annual values: Fiscal year 2025: $140.35 million | Fiscal year 2024: $182.27 million | Fiscal year 2023: $218.85 million | Fiscal year 2022: $240.40 million | Fiscal year 2021: $269.39 million | Fiscal year 2020: $348.64 million | Fiscal year 2019: $755.63 million | Fiscal year 2018: $41.40 million | Fiscal year 2017: $60.16 million | Fiscal year 2016: $59.06 million | Fiscal year 2015: $103.05 million | Fiscal year 2014: $59.03 million | Fiscal year 2013: $10.23 million | Fiscal year 2012: $7.37 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: